TORONTO, ONTARIO -- (MARKET WIRE) -- April 30, 2007 -- PharmEng International Inc. (TSX VENTURE: PII),a full-service consulting and contract manufacturing company, today reported its results for the period ended December 31, 2006. The Company has demonstrated continued strong revenue growth of 43% during 2006 over the previous year and continues to reinvest in its business plan. While this growth in 2007 continues, management is focused on reducing operational expenses in order to return to previous profit margins.
